risperidone has been researched along with Incipient Schizophrenia in 13 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results suggest that OCD patients with and without comorbid chronic tic disorders or schizotypal personality disorder may respond to the addition of low-dose risperidone to ongoing SRI therapy." | 9.09 | A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. ( Epperson, CN; McDougle, CJ; Pelton, GH; Price, LH; Wasylink, S, 2000) |
| "These results suggest that OCD patients with and without comorbid chronic tic disorders or schizotypal personality disorder may respond to the addition of low-dose risperidone to ongoing SRI therapy." | 5.09 | A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. ( Epperson, CN; McDougle, CJ; Pelton, GH; Price, LH; Wasylink, S, 2000) |
| "•We assessed self-monitoring in schizotypal personality disorder (SPD) using ERPs." | 2.82 | Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism. ( Antonijoan, RM; Corripio, I; Grasa, E; Mañanas, MÀ; Münte, TF; Pérez, V; Rabella, M; Riba, J; Romero, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmechtig, A | 2 |
| Lees, J | 2 |
| Grayson, L | 2 |
| Craig, KJ | 2 |
| Dadhiwala, R | 2 |
| Dawson, GR | 2 |
| Deakin, JF | 2 |
| Dourish, CT | 2 |
| Koychev, I | 2 |
| McMullen, K | 2 |
| Migo, EM | 1 |
| Perry, C | 2 |
| Wilkinson, L | 2 |
| Morris, R | 1 |
| Williams, SC | 1 |
| Ettinger, U | 2 |
| Rabella, M | 1 |
| Grasa, E | 1 |
| Corripio, I | 1 |
| Romero, S | 1 |
| Mañanas, MÀ | 1 |
| Antonijoan, RM | 1 |
| Münte, TF | 1 |
| Pérez, V | 1 |
| Riba, J | 1 |
| Takahashi, T | 1 |
| Wood, SJ | 1 |
| Yung, AR | 1 |
| Soulsby, B | 1 |
| McGorry, PD | 1 |
| Suzuki, M | 1 |
| Kawasaki, Y | 1 |
| Phillips, LJ | 2 |
| Velakoulis, D | 1 |
| Pantelis, C | 1 |
| Gaebel, W | 1 |
| Riesbeck, M | 1 |
| Wölwer, W | 1 |
| Klimke, A | 1 |
| Eickhoff, M | 1 |
| von Wilmsdorff, M | 1 |
| Lemke, M | 1 |
| Heuser, I | 1 |
| Maier, W | 1 |
| Huff, W | 1 |
| Schmitt, A | 1 |
| Sauer, H | 1 |
| Riedel, M | 1 |
| Klingberg, S | 1 |
| Köpcke, W | 1 |
| Ohmann, C | 1 |
| Möller, HJ | 1 |
| Edwards, J | 1 |
| McMurray, N | 1 |
| Francey, S | 1 |
| Walters, J | 1 |
| Williams, S | 1 |
| Barkus, E | 1 |
| Stone, WS | 1 |
| Hsi, X | 1 |
| Giuliano, AJ | 1 |
| Tan, L | 1 |
| Zhu, S | 1 |
| Li, L | 1 |
| Seidman, LJ | 1 |
| Tsuang, MT | 1 |
| Weiner, I | 1 |
| Schiller, D | 1 |
| Gaisler-Salomon, I | 1 |
| Koenigsberg, HW | 1 |
| Reynolds, D | 1 |
| Goodman, M | 1 |
| New, AS | 1 |
| Mitropoulou, V | 1 |
| Trestman, RL | 1 |
| Silverman, J | 1 |
| Siever, LJ | 1 |
| Rybakowski, JK | 2 |
| Drózdz, W | 2 |
| Borkowska, A | 2 |
| Crespo-Facorro, B | 1 |
| Pelayo-Terán, JM | 1 |
| Pérez-Iglesias, R | 1 |
| Ramírez-Bonilla, M | 1 |
| Martínez-García, O | 1 |
| Pardo-García, G | 1 |
| Vázquez-Barquero, JL | 1 |
| McDougle, CJ | 1 |
| Epperson, CN | 1 |
| Pelton, GH | 1 |
| Wasylink, S | 1 |
| Price, LH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Maintenance Treatment vs. Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia[NCT00159120] | Phase 4 | 71 participants (Anticipated) | Interventional | 2001-11-30 | Completed | ||
| Risk of Breakthrough Symptoms On Antipsychotic Maintenance Medication When Remitted Patients Are Treated With Long-Acting Injectable Medications[NCT05473741] | 180 participants (Anticipated) | Observational | 2023-01-09 | Recruiting | |||
| Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder[NCT00158028] | 25 participants (Actual) | Interventional | 1995-11-30 | Completed | |||
| A D1 Agonist For Working Memory Enhancement In The Schizophrenia Spectrum[NCT02507206] | Phase 2 | 120 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 trials available for risperidone and Incipient Schizophrenia
| Article | Year |
|---|---|
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Nic | 2013 |
Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.
Topics: Adult; Brain Mapping; Contingent Negative Variation; Cross-Over Studies; Dopamine Antagonists; Doubl | 2016 |
Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
Topics: Adolescent; Adult; Antipsychotic Agents; Atrophy; Bipolar Disorder; Cognitive Behavioral Therapy; Co | 2009 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; | 2011 |
Comparison of experiences of stress and coping between young people at risk of psychosis and a non-clinical cohort.
Topics: Adaptation, Psychological; Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Cognitive Beha | 2012 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Fema | 2012 |
Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study.
Topics: Adolescent; Adult; Antipsychotic Agents; China; Cluster Analysis; Cognitive Dysfunction; Double-Blin | 2012 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Risperidone in the treatment of schizotypal personality disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Comorbidity; Double-Blind Method; Drug Administration Sched | 2003 |
Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Comorbidity; F | 2007 |
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Comorbidity; Dopamine Antagonists; Double-Blind Method; Drug Administra | 2000 |
3 other studies available for risperidone and Incipient Schizophrenia
| Article | Year |
|---|---|
Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
Topics: Animals; Antipsychotic Agents; Conditioning, Psychological; Inhibition, Psychological; Male; Rats; R | 2003 |
Low dose risperidone in the treatment of schizophrenia-like symptoms in high-risk subjects.
Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Male; Ris | 2003 |
Long-term administration of the low-dose risperidone in schizotaxia subjects.
Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Drug Administration Schedule; Eye Move | 2007 |